Hubei Guangji Pharmaceutical Co., Ltd. (SHE:000952)
China flag China · Delayed Price · Currency is CNY
5.36
-0.07 (-1.29%)
Nov 18, 2026, 3:04 PM CST

SHE:000952 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
-367.1-404.49-295.29-140.2550.33110.11
Depreciation & Amortization
160.27160.27165.14119.9598.3191.26
Other Amortization
1.811.811.920.770.010.12
Loss (Gain) From Sale of Assets
-0.55-0.552.4-0.254.31-0.54
Asset Writedown & Restructuring Costs
265.29265.2930.680.1212.281.15
Loss (Gain) From Sale of Investments
-18.38-18.3827.929.24-6.3-18.72
Provision & Write-off of Bad Debts
7.287.28-2.80.14--
Other Operating Activities
72.6644.1947.846.8914.1213.91
Change in Accounts Receivable
-118.47-118.47156.17-53.06-102.06-66.93
Change in Inventory
47.7947.79-14.16-100.18-64.33-4.35
Change in Accounts Payable
90.6390.63-114.2-44.8729.87-47.38
Change in Other Net Operating Assets
-10.75-10.750.120.9110.83-
Operating Cash Flow
126.2960.430.66-148.9645.0875.91
Operating Cash Flow Growth
30.95%9120.65%---40.61%-36.42%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-10.29-35.64-154.93-566.13-203.71-96.61
Sale of Property, Plant & Equipment
25.8552.160.3500.74
Divestitures
-55.44----
Investment in Securities
----80-20
Other Investing Activities
----1.971.76
Investing Cash Flow
15.5624.79-152.78-565.78-121.74-114.1

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Issued
---20--
Long-Term Debt Issued
-742.68766.311,221739.45388.65
Total Debt Issued
811.81742.68766.311,241739.45388.65
Long-Term Debt Repaid
--805.82-660.49-559.51-438.48-399.77
Lease Payments
-----1.18-0.24
Total Debt Repaid
-921.1-805.82-660.49-559.51-438.48-399.77
Net Debt Issued (Repaid)
-109.29-63.13105.82681.09300.97-11.12
Issuance of Common Stock
----36.19-
Repurchase of Common Stock
-11.34-11.34-14.51-0.44--
Common Dividends Paid
-43.23-50.95-50.46-31.56-40.24-35.65
Other Financing Activities
12.94-0.012524.02-
Financing Cash Flow
-150.91-125.4342.84701.09300.94-46.77

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-2.820.781.210.121.43-1.5
Net Cash Flow
-11.88-39.42-108.07-13.54225.71-86.47

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
11624.79-154.28-715.1-158.63-20.7
Free Cash Flow Growth
491.16%-----
Free Cash Flow Margin
18.41%3.97%-24.15%-96.92%-19.89%-2.63%
Free Cash Flow Per Share
0.340.07-0.44-2.02-0.45-0.06
Levered Free Cash Flow
56.92224.68-71.87-515.16-137.81-64.25
Unlevered Free Cash Flow
85.45256.65-33.14-484.44-124.63-53.81
Free Cash Flow After Leases
11624.79-154.28-715.1-159.81-20.94

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
25.2711.62-33.6220.538.9137.53
Change in Working Capital
5.025.0222.88-185.58-127.98-121.37